Evaluation effect of Dinvl for Covid19 infectio
Phase 2
Recruiting
- Conditions
- Pneumonia induced by covid19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20200509047373N1
- Lead Sponsor
- Health Medicine Chemistry Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients up18 years old hospitalized
Patient with SpO2:85-89% on room air at admission (if correct with nasal O2 maximum 6 liter/min to SpO2>=90 )
Patients with SpO2: 90-93% and RR>=30 clinical compatible
patients with positive RT-PCR test or consistent HRCT to covid19
pneumonia Sign the study participation form
Exclusion Criteria
Known sensitivity to plant compounds.
Pregnant woman Lactating woman Patients with active peptic.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to clinical recovery. Timepoint: Control clinical signs daily until discharge from the hospital. Method of measurement: Fever control with thermometer, oxygen saturation control with pulsoximetry.
- Secondary Outcome Measures
Name Time Method 14 days readmission after discharge. Timepoint: Up to 14 days after discharge. Method of measurement: All patients will be given a contact number to notify them if they are hospitalized again. All patients will be monitored by phone weekly for up to 4 weeks after the first day they are admitted.